In Conversation With… Yoshiya Tanaka MD, PhD
"We know that it is not easy to taper patients safely. So if we find a patient’s toxicity scores are worsening we can try an immunosuppressant or a biologic drug and then we need to track to see if ...
In conversation with... Murray Urowitz MD. FRCP(C)
“If you ask the doctor and patient what they want most of all, their unanimous answer will be, ‘not to have to use steroids.’” Murray Urowitz MD. FRCP(C) is a rheumatologist who has spent the “last ...
In conversation with... Michelle Petri MD MPH
“There has to be an acceptance that steroids are now an undesirable part of treating most rheumatic diseases, and our prescribing behavior must change.” Michelle Petri MD, MPH is a leading ...
In conversation with... James T. Rosenbaum, MD
“Steroid toxicity is rampant and it can be fatal… bringing it onto the radar screen of the practicing physician is really, really important.” James T. Rosenbaum M.D. fell into ophthalmology by chance ...
Curious about the true cost of steroid-toxicity?
Download our infographic today
